Lixte Biotechnology Holdings (FRA:8640) Institutional Ownership : 0.48% (As of Jul. 24, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Lixte Biotechnology Holdings Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Lixte Biotechnology Holdings's institutional ownership is 0.48%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Lixte Biotechnology Holdings's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Lixte Biotechnology Holdings's Float Percentage Of Total Shares Outstanding is 91.24%.

Lixte Biotechnology Holdings Institutional Ownership Historical Data

The historical data trend for Lixte Biotechnology Holdings's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lixte Biotechnology Holdings Institutional Ownership Chart

Lixte Biotechnology Holdings Historical Data

The historical data trend for Lixte Biotechnology Holdings can be seen below:

	2023-04-30	2023-05-31	2023-06-30	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31
Institutional Ownership	1.25	1.18	1.25	1.13	0.93	0.63	0.48	0.48	0.48	0.48

Lixte Biotechnology Holdings Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Lixte Biotechnology Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lixte Biotechnology Holdings Inc (FRA:8640) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

LIXT:USA

Address

680 East Colorado Boulevard, Suite 180, Pasadena, CA, USA, 91101

Website

https://www.lixte.com

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Lixte Biotechnology Holdings Headlines

No Headlines